Expansion Therapeutics: Expansion Therapeutics Appoints Renato Skerlj, Ph.D., as Chief Executive Officer
Expansion Therapeutics, Inc., a biotechnology company advancing transformative medicines to patients with RNA-mediated diseases, today announced the appointment of Renato Skerlj, Ph.D.,
Read full article »
Expansion Therapeutics is a Massachusetts-based biotechnology company that develops and commercializes small molecule medicines for the treatment of RNA-mediated diseases.
Read more